Latest news
Has Ultragenyx Pharmaceutical (RARE) Fallen Far Enough To Avoid Overvaluation? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 03:22:00 GMTUltragenyx Pharmaceutical (RARE) Following Q2 Results Looks Close To Fair Value - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 22:12:37 GMTUltragenyx (RARE) Stock Looks Overvalued After Record Revenue Update - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:31:45 GMTState Street Corporation (RARE) discloses 6.3% Ultragenyx ownership on Schedule 13G - Stock TitanStock Titan · Fri, 07 Aug 2026 15:06:31 GMTUltragenyx releases 2025 impact report on rare disease work - Investing.comInvesting.com · Fri, 07 Aug 2026 07:34:00 GMTUltragenyx (RARE) Stock Revenue Record Clashes With Ongoing Cash Burn - simplywall.stsimplywall.st · Thu, 06 Aug 2026 06:15:57 GMTBlackRock, Inc. Buys Ultragenyx Pharmaceutical Inc (RARE) -- Sha - GuruFocusGuruFocus · Thu, 06 Aug 2026 02:46:45 GMTUltragenyx Pharma Remains on Path to Profitability in 2027 >RARE - MoomooMoomoo · Wed, 05 Aug 2026 16:24:44 GMT